INTERNATIONAL PATENT: ALEBUND PHARMACEUTICALS (HONG KONG) LIMITED FILES APPLICATION FOR "METHOD FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE"

GENEVA, Oct. 3 -- ALEBUND PHARMACEUTICALS (HONG KONG) LIMITED (1/F., No. 50 Tai Wan New Village, Yung Shue Wan, Lamma IslandHong Kong) filed a patent application (PCT/CN2025/084645) for "METHOD FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE" on Mar 25, 2025. With publication no. WO/2025/201305, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TIAN, Jin (1206 Hong Kong Plaza South Tower, 283 Central Huaihai RoadHuangpu District, Shanghai 200021), SHU, Chutian (1206 Hong Kong Plaza South Tower, 283 Central Huaihai...